Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  HBM Healthcare Investments AG    HBMN   CH0012627250

HBM HEALTHCARE INVESTMENTS AG

(HBMN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
02/25/2021 02/26/2021 03/01/2021 03/02/2021 03/03/2021 Date
338.5(c) 325(c) 341(c) 340.5(c) 338(c) Last
8 604 10 930 4 166 3 803 6 551 Volume
+0.59% -3.99% +4.92% -0.15% -0.73% Change
More quotes
Financials
Sales 2021 - - -
Net income 2021 690 M 751 M 751 M
Net Debt 2021 46,0 M 50,0 M 50,0 M
P/E ratio 2021 3,41x
Yield 2021 3,33%
Sales 2022 - - -
Net income 2022 171 M 186 M 186 M
Net Debt 2022 45,0 M 49,0 M 49,0 M
P/E ratio 2022 13,7x
Yield 2022 3,64%
Capitalization 2 351 M 2 564 M 2 558 M
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 700
Free-Float 83,0%
More Financials
Company
HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition,... 
More about the company
All news about HBM HEALTHCARE INVESTMENTS AG
03/01HBM HEALTHCARE INVESTMENTS  : NAV Climbs 51% in Fiscal Year to February; Shares ..
MT
03/01HBM HEALTHCARE INVESTMENTS  : Key Figures 28.02.2021
PU
03/01HBM HEALTHCARE INVESTMENTS  : Key Figures 28.02.2021
EQ
03/01EQS-ADHOC  : Key Figures 28.02.2021
DJ
02/16HBM HEALTHCARE INVESTMENTS  : Key Figures 15.02.2021
EQ
02/16EQS-ADHOC  : Key Figures 15.02.2021
DJ
02/01HBM HEALTHCARE INVESTMENTS  : Portfolio Company Viela Bio Sold to Horizon Therap..
MT
02/01HBM HEALTHCARE INVESTMENTS  : NAV Jumps 44% in Fiscal Year to January
MT
02/01HBM HEALTHCARE INVESTMENTS  : Horizon Therapeutics to acquire HBM portfolio comp..
EQ
02/01EQS-ADHOC : Horizon Therapeutics to acquire HBM portfolio company Viela Bio for ..
DJ
02/01EQS-ADHOC  : Key Figures 31.01.2021
DJ
02/01HBM HEALTHCARE INVESTMENTS  : Key Figures 31.01.2021
EQ
01/22HBM HEALTHCARE INVESTMENTS  : Fiscal Q3 Profit Grows as Portfolio Values Rise
MT
01/22HBM HEALTHCARE INVESTMENTS  : Quarterly Report December 2020
EQ
01/18HBM HEALTHCARE INVESTMENTS  : Key Figures 15.01.2021
EQ
More news
News in other languages on HBM HEALTHCARE INVESTMENTS AG
02/01HBM : Horizon Therapeutics reprend Viela Bio pour 3,05 milliards de dollars
02/01HBM : Horizon Therapeutics übernimmt Portfoliofirma Viela für 3,05 Mrd USD
02/01HBM HEALTHCARE INVESTMENTS  : Horizon Therapeutics übernimmt HBM-Portfoliountern..
02/01EQS-ADHOC  : Horizon Therapeutics übernimmt HBM-Portfoliounternehmen Viela Bio f..
02/01Horizon Therapeutics übernimmt HBM-Portfoliounternehmen Viela Bio für USD 3.0..
More news
Analyst Recommendations on HBM HEALTHCARE INVESTMENTS AG
More recommendations
Chart HBM HEALTHCARE INVESTMENTS AG
Duration : Period :
HBM Healthcare Investments AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HBM HEALTHCARE INVESTMENTS AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 355,00 CHF
Last Close Price 338,00 CHF
Spread / Highest target 5,03%
Spread / Average Target 5,03%
Spread / Lowest Target 5,03%
EPS Revisions
Managers and Directors
NameTitle
Andreas Wicki Chief Executive Officer
Erwin Troxler Chief Financial Officer
Hans-Peter Hasler Chairman
Heinz Riesenhuber Vice Chairman
Eduard Enrico Holdener Director
Sector and Competitors
1st jan.Capitalization (M$)
HBM HEALTHCARE INVESTMENTS AG10.82%2 564
BLACKROCK, INC.-0.72%109 333
UBS GROUP AG17.08%56 679
THE BLACKSTONE GROUP INC.7.38%46 439
T. ROWE PRICE GROUP INC.12.06%38 671
BANK OF NEW YORK MELLON CORPORATION (THE)2.73%38 313